HIGHLIGHTS
- who: Inger Steenoven from the 118, HV Amsterdam, The Netherlands have published the research: Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach, in the Journal: (JOURNAL)
- what: The authors aimed to identify novel CSF biomarkers for DLB using a high-throughput proteomic approach. In view of the decrease of VGF and SCG2 in CSF of patients with different neurodegenerative disorders and their localization in synaptic vesicles, the authors propose that VGF and SCG2 are markers for synaptic degeneration. The use of this study design increases the generalizability of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.